DALLAS, Nov. 10, 2005 (PRIMEZONE) -- StockGuru.com has issued a Profile Report on Response Biomedical Corporation (OTCBB:RPBIF) (TSX-V:RBM), a leading diagnostics company commercializing rapid clinical and environmental tests on its proprietary RAMP platform. The report is authored by Shailesh Dhuri, CFA and Senior Financial Analyst for Pentony Enterprises. The report discusses the company's relationships with 3M Health Care, Roche Diagnostics and the new opportunities developed in the market due to the threat of avian flu.
Mr. Dhuri issues the following conclusion in the report:
"The Company has developed attractive technology which has potential for applications in the detection of multiple diseases and medical conditions. Given the need for accurate detection and diagnosis in the clinical and environmental markets along with the development of Flu A as a global threat, the Company should experience significant revenue growth as its products find acceptance in the marketplace. In addition, the Company has developed global alliances for creating new applications of its technology, and these alliances have positioned the Company to become a significant global competitor."
To view the complete Profile Report authored by Shailesh Dhuri, please visit: http://www.stockguru.com/profiles/rpbif/report.php.
To view the StockGuru.com Profile for Response Biomedical Corporation, please visit: http://www.stockguru.com/profiles/rpbif/index.php.
In October, Stock Guru Publisher John Pentony interviewed Response Biomedical Corporation's President and CEO, Mr. Bill Radvak. In the interview, Mr. Radvak gave a comprehensive update on the company and the competitive advantages of the company's products.
To listen to the interview, please visit: http://www.stockguru.com/profiles/rpbif/interview.php.
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm.
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or e-mail publisher@stockguru.com. Our services include our Morning, Midday, and After The Bell news releases. Additionally, we profile publicly traded companies on our Web site, we do interviews with CEOs or other key executives on our Web site, and we have our financial writers cover our companies.
Statements contained in this news release relating to future results, events and expectations, including statements relating to the proposed financing, are forward-looking statements within the meaning of Section 21E of the United States Securities Exchange Act of 1934. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such factors include, among others, those described in the Company's annual report on Form 20-F.
Disclosure: Pentony Enterprises LLC and TalkingStocks.com LLC have been compensated a total of $10,000 from the company for profile coverage. Neither TalkingStocks.com, LLC, nor Pentony Enterprises, LLC, are registered investment advisers or broker/dealers. TalkingStocks.com, LLC and Pentony Enterprises, LLC makes no recommendation that the purchase of securities of companies profiled in this Web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.